NCT00570323View on ClinicalTrials.gov

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2016

Study Completion Date

December 5, 2018

Conditions

Breast Cancer

Interventions

DRUG

Arimidex

Aromatase inhibitors

DRUG

Faslodex

Hormone Receptor

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Mothaffar Rimawi

OTHER